- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 14, 2024
Product Development
Clinical report: Data from Gilead, KalVista, Takeda, Synlogic and AN2
What Gilead’s CD47 failure means for the class; KalVista to submit HAE program; Takeda advances narcolepsy therapy; and more
BioCentury | Oct 14, 2022
Discovery & Translation
Codiak’s pan beta-coronavirus vaccine; plus CNS-penetrating AAV9 variants and more
BioCentury’s roundup of translational news
BioCentury | Nov 19, 2012
Regulation
Antibiotics reset
GAIN Act, FDA stance only first steps to refilling antibiotic pipeline in U.S.
Items per page:
1 - 10 of 24